• Vasculitis, Systemic
  • Mycoplasma pneumoniae, Culture
  • Acetylcholine Receptor (AChR) Antibody
  • Lung Cancer Gene Mutation Panel
  • Carnitine, Total, Serum/Plasma
  • PML-RARA (Promyelocytic Leukemia/Retinoic Acid Receptor Alpha) Translocation, t(15;17) Analysis
  • Integrin Subunit Beta 3 (ITGB3) Gene Mutation Analysis
  • Newborn Aneuploidy Detection, FISH
  • Chlamydia trachomatis and Neisseria gonorrhoeae NA, Liquid Cytology
  • T Cell Acute Lymphoblastic Leukemia (T-ALL), FISH, Blood
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Overview
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.